Neurocysticercosis - Is the Elimination of Parasites Beneficial?

New England Journal of Medicine

Volumn 350, Issue 3, 2004, Pages 280-282

  Sotelo, Julio ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; CORTICOSTEROID; PLACEBO; PRAZIQUANTEL;

BRAIN CALCIFICATION; BRAIN CYST; BRAIN MALARIA; BRAIN SURGERY; BRAIN TISSUE; CLINICAL STUDY; CYST; CYSTICERCOSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG PENETRATION; DYSPNEA; ECONOMIC ASPECT; EDITORIAL; EPILEPSY; ERADICATION THERAPY; EXPECTATION; FOLLOW UP; FOOD CONTAMINATION; GRANULOMATOUS INFLAMMATION; HEADACHE; HOST RANGE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIFE CYCLE; NEUROCYSTICERCOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATIENT SATISFACTION; POVERTY; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SEIZURE; SIDE EFFECT; SWINE; T1 WEIGHTED MAGNETIZATION TRANSFER SPIN ECHO IMAGING; TAENIA SOLIUM; TAENIASIS; TUBERCULOSIS; VOMITING;

ALBENDAZOLE; ANTICESTODAL AGENTS; BRAIN DISEASES; FOLLOW-UP STUDIES; GRANULOMA; HUMANS; NEUROCYSTICERCOSIS; SEIZURES;

EID: 0347949552     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe038218     Document Type: Editorial

References (13)

1. Riley T, White AC Jr. Management of neurocysticercosis. CNS Drugs 2003;17:577-91.
2. Sotelo J. Neurocysticercosis. In: Aminoff MJ, Daroff RB, eds. Encyclopedia of the neurological sciences. San Diego, Calif.: Academic Press, 2003:474-5.
3. Proaño JV, Madrazo I, Avelar F, López-Felix B, Díaz G, Grijalva I. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001;345:879-85.
4. Sotelo J. Neurocysticercosis: eradication of cysticercosis is an attainable goal. BMJ 2003;326:511-2.
5. Pradhan S, Kathuria MK, Gupta RK. Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Ann Neurol 2000;48:181-7.
6. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-58.
7. Kim SK, Wang KC, Paek SH, Hong KS, Cho BK. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea. Surg Neurol 1999;52:563-9.
8. Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr 2003;143:111-4.
9. Pérez López C, Isla Guerrero A, Álvarez F, et al. Actualización en el tratamiento de la neurocisticercosis. Rev Neurol 2003;36:805-11.
10. Singhi P, Dayal D, Khandelwal N. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J 2003; 22:268-72.
11. Bharucha NE. Epidemiology of epilepsy in India. Epilepsia 2003;44:Suppl 1:9-11.
12. Rosenfeld EA, Byrd SE, Shulman ST. Neurocysticercosis among children in Chicago. Clin Infect Dis 1996;23:262-8.
13. Salgado P, Rojas R, Sotelo J. Cysticercosis: clinical classification based on imaging studies. Arch Intern Med 1997;157:1991-7.